A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis

Conclusions: Over 24 weeks, phase lesions were reduced significantly in the RRMS group. These preliminary results suggest that SWI-filtered phase may become a useful tool for monitoring RRMS disease activity.

http://tan.sagepub.com/cgi/content/abstract/8/2/59?rss=1

Source: Therapeutic Advances in Neurological Disorders - March 10, 2015 Category: Neurology Authors: Zivadinov, R., Dwyer, M., Markovic-Plese, S., Hayward, B., Bergsland, N., Heininen-Brown, M., Carl, E., Kennedy, C., Dangond, F., Weinstock-Guttman, B. Tags: Original Research Source Type: research